NCT00072124View on ClinicalTrials.gov

Dacarbazine and/or Cisplatin Compared With Complete Metastasectomy in Treating Patients With Stage IV Melanoma

PHASE3CompletedINTERVENTIONAL

Timeline

Start Date

September 30, 2003

Study Completion Date

May 31, 2005

Conditions

Melanoma (Skin)

Interventions

DRUG

cisplatin

DRUG

dacarbazine

PROCEDURE

conventional surgery

Trial Locations (1)

20892-1182

Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support, Bethesda

All Listed Sponsors

lead

National Cancer Institute (NCI)

NIH

NCT00072124 - Dacarbazine and/or Cisplatin Compared With Complete Metastasectomy in Treating Patients With Stage IV Melanoma | Biotech Hunter | Biotech Hunter